Press Releases

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).

Proscia Strengthens Leadership Position In Global Diagnostic Pathology Market

New KLAS Research report and research study conducted with Quest Diagnostics highlight company’s customer and product momentum

WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research

The task force will evaluate AI's use in various aspects of clinical trials, including protocol design, consent considerations, patient privacy and confidentiality, and participant recruitment. It will also evaluate AI when it is being studied as an investigational product for use in medical care.

ELRIG UK and The Protein Society Partner to Advance Protein Sciences in Drug Discovery

Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK from 18–19 November 2024

Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers

Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions

Primerdesign Launches Real-time PCR Workflow for Onsite Detection of Norovirus in Oysters

• genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue • Onsite analysis helps ensure shellfish quality and safety across the production line, reducing public health risk • Developed in collaboration with oyster farmers and Shellfish Association of Great Britain • Primerdesign to present new developments in Norovirus testing at ACIG: Aquaculture innovation and supply chain resilience (25 June 2024)

Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience

AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.

Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

Huateng Pharma to Exhibit at CPHI China 2024

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

Streck Establishes Partnership with Longhorn Vaccines and Diagnostics to Distribute PrimeStore® MTM Worldwide

Association for Molecular Pathology Publishes Evidence-based Recommendations for Tumor Mutational Burden Testing

AMP published a set of evidence-based recommendations for the analytical validation and reporting of TMB testing as a potential predictive biomarker for ICI therapies

FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning

FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials

Syngene launches platform for rapid, enhanced protein production

Indica Labs Announces AI-Powered HALO® Software Release for Digital Pathology Research in Life Sciences

Indica Labs announced today the release of the transformative new version of its industry leading life sciences software.

Sakura Finetek Europe B.V. advances its laboratory automation with the Tissue-Tek xPrint® LP Laser Cassette Printer

Sakura Finetek Europe announces the launch of its newest advancement in tissue sample identification bringing laboratory workflows to the next level.

PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024

PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. The product pairing provides unprecedented single-cell and spatial resolution of the tumor microenvironment from routine pathology samples to facilitate biomarker discovery and deeper understanding of treatment response for the next generation of cancer therapeutics. The expansion of the Explore™ portfolio comes at a time when AI-pathology is experiencing accelerated large-scale adoption across the diagnostic and biopharma industries. “As cancer rates continue to rise, the demand for advanced precision medicine tools that provide accurate biological in